Maggie Glawatz, APRN
Gerontology · Bellingham, WANPI 1376963223
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Seagen Inc. at 38.7% of the total. Reporting peaked in 2022 at $370 and has fallen 74.2% since, to $96 in 2025.
Across 24 payments — averaging $29.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$273
- Incyte Corporation$137
- Novartis$62
- AbbVie$56
- Sanofi$24
- Johnson & Johnson$22
- plus $132 from 8 others
What the payments were for
- Food & beverage$40858%
- Education$29842%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 6 | $273 |
| Incyte Corporation | 3 | $137 |
| Novartis | 3 | $62 |
| AbbVie | 2 | $56 |
| Sanofi | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Deciphera Pharmaceuticals Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| GSK | 1 | $13 |
How this compares
$706 in reported general payments places this provider in the 70th percentile of 105 gerontology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 11 | $10,144 |
| Fentanyl | 40 | $3,582 |
| Oxycodone Hcl | 65 | $1,174 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $745 |
| Duloxetine Hcl | 29 | $564 |
| Morphine Sulfate | 13 | $440 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $279 |
| Prochlorperazine Maleate | 13 | $215 |
| Hydromorphone Hcl | 18 | $173 |
| Gabapentin | 25 | $127 |
| Olanzapine | 12 | $104 |
| Alprazolam | 16 | $65 |
| Tramadol Hcl | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Bellingham
- Lori BurtonBellingham$850
- Sarah LeeBellingham$747
- Amy WoodruffTacoma$118K
- Peter WilcoxSilverdale$16K
- Kristi ParrisSilverdale$10K
- Samuel GodinSilverdale$7K
- Byron TatschSpokane Valley$4K
- Catherine RehbergerTacoma$4K
- Nachole BrownSeattle$4K
- Si FengRichland$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.